Vaccitech PLC
Change company Symbol lookup
Select an option...
VACC Vaccitech PLC
PNR Pentair PLC
AAL American Airlines Group Inc
AMD Advanced Micro Devices Inc
IDAI T Stamp Inc
VZ Verizon Communications Inc
CETX Cemtrex Inc
RNXT RenovoRx Inc
BNTX BioNTech SE
ARTW Art's Way Manufacturing Co Inc
Go

Health Care : Biotechnology |
Based in United Kingdom
Company profile

Vaccitech plc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The Company uses its platform to develop product candidates that target immune responses against pathogens and tumor cells. The Company has a pipeline of both clinical and preclinical stage therapeutic and prophylactic programs. Its therapeutic programs include VTP-300 for the treatment of chronic hepatitis B infection (CHB), VTP-200 for the treatment of human papilloma virus infection (HPV), VTP-850 for the treatment of prostate cancer and VTP-600 for the treatment of non-small cell lung cancer (NSCLC). Its prophylactic programs include VTP-400 for the prevention of herpes zoster (shingles), and VTP-500 for the prevention of the Middle East respiratory syndrome (MERS).

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$2.27
Day's Change
-0.20 (-8.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.31
Day's Low
2.16
Volume
(Heavy Day)

Today's volume of 168,210 shares is on pace to be much greater than VACC's 10-day average volume of 164,005 shares.

168,210

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Freshworks Inc. (FRSH) Investors of Class Action and to Actively Participate

11:00 am ET December 30, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / December 30, 2022 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Freshworks, Inc. ("Freshworks" or the "Company") (NASDAQ:FRSH) and certain of its officers, on behalf of a class consisting of all persons and entities that purchased or otherwise acquired Freshworks' securities from the September 2021 initial public offering ("IPO"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/frsh

Bronstein, Gewirtz and Grossman, LLC, Friday, December 30, 2022, Press release picture

This class action seeks to recover damages against Defendants for alleged violations of the Securities Act of 1933 (the "Securities Act").

Freshworks provides customer engagement software for businesses. On or about September 22, 2021, Freshworks conducted its IPO, offering 28.5 million shares of its common stock to the investing public at a price of $36 per share (the "Offering Price").

According to the complaint filed in the U.S. District of California, Northern District and captioned Sundaram v. Freshworks Inc. et al., Case No. 3:22-cv-6750, the Offering Documents used to effectuate Freshworks' IPO were false and misleading and omitted to state that, at the time of the offering, the Company's business had encountered obstacles. As a result, Freshworks' net dollar retention rate was plateauing, and its revenue growth rate and billings were decelerating. As the truth about the Company's business reached the market, the value of its shares declined dramatically, causing Freshworks investors to suffer significant damages. Indeed, by the commencement of the action, Freshworks' shares traded as low as $10.51 per share, representing a decline of over 70% from the Offering Price.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/frsh or contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Freshworks Inc. you have until January 3,2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Nathanson 212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC





View source version on accesswire.com:

https://www.accesswire.com/733454/Deadline-Alert-Bronstein-Gewirtz-Grossman-LLC-Notifies-Freshworks-Inc-FRSH-Investors-of-Class-Action-and-to-Actively-Participate



comtex tracking

COMTEX_421591770/2457/2022-12-30T11:00:53

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.